The article describes how the linkage of nucleotide metabolism enables hyperactivation of the NLRP3 inflammasome in obesity[4]. Blocking dNTP transport into mitochondria abrogated NLRP3 hyperactivation in macrophages from both obese subjects and SAMHD1-deficient mice[4]. The NLRP3 inflammasome is a key regulator of obesity- and fatty acid-associated metabolic inflammation[1][2]. Saturated fatty acids, such as palmitate and ceramide, activate NLRP3 via AMPK-autophagy and mitochondrial reactive oxygen species[3]. Obesity leads to chronic low-level inflammation with infiltration of immune cells into adipose tissue[1]. NLRP3-null mice on a high-fat diet show improved insulin sensitivity and reduced inflammation in adipose tissue, liver, and pancreas[2]. Caloric restriction inhibits NLRP3 activation through activation pathways such as AMPK[2]. These findings point to metabolic reprogramming as a target for regulating inflammation in obesity[4].